BIRC5 and neoplasm: Therefore, the anti-tumor effects of peptide vaccines targeting MHCI (BIRC5 and EphA2) and MHCII (PADRE) peptides were investigated using a vaccine composed of long multi-epitope peptides in this GL261 mouse model.